Features of using of a fixed combination of rosuvastatin and ezetimibe for effective hypolipidemic therapy-Reference-Cited by-同舟云学术

Features of using of a fixed combination of rosuvastatin and ezetimibe for effective hypolipidemic therapy

Published:2020-10-15 Issue:14 Volume: Page:26-32
ISSN:2658-5790
Container-title:Meditsinskiy sovet = Medical Council
language:
Short-container-title:Medicinskij sovet

Author:

Alekseeva I. A.¹^ORCID,Ezhov M. V.¹^ORCID

Affiliation:

1. Myasnikov Research Institute of Clinical Cardiology, National Medical Research Center of Cardiology

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference28 articles.

1. Mach F., Baigent C., Catapano A., Koskinas K., Casula M., Badimon L. et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardio vascular risk: The task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). European Heart Journal. 2020;41(1):111-188. doi: 10.1093/eurheartj/ehz455.

2. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937-952. doi: 10.1016/S0140-6736(04)17018-9.

3. Metelskaya V.A., Shalnova S.A., Deev A.D., Perova N.V., Gomyranova N.V., Litinskaya O.A. et al. Analysis of atherogenic dyslipidemias prevalence among population of Russian Federation (resultsof the ESSE-RF Study). Profilakticheskaya meditsina = Russian Journal of Preventive Medicine and Public Health. 2016;19(1):15-23. (In Russ.) doi: 10.17116/profmed201619115-23.

4. Meshkov A.N., Ershova A.I., Deev A.D., Metelskaya V.A., Zhernakova Yu.V., Rotar O.P. et al. Distribution of lipid profile values in economically active men and women in Russian Federation: results of the ESSE-RF study for the years 2012-2014. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2017;16(4):62-67. (In Russ.) doi: 10.15829/1728-8800-2017-4-62-67.

5. Ezhov M.V., Lazareva N.V., Sagaydak O.V., Vygodin V.A., Chubikina U.V., Blizniuk S.A. et al. Prevalence of Dyslipidemia and Statins Use In Russian Acute Coronary Syndrome Registry. Ateroskleroz i Dislipidemii = The Journal of Atherosclerosis and Dyslipidemias. 2018;1(30):47-57. (In Russ.) Available at: https://noatero.ru/ru/noa/jurnal/2018g-no1-30.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined hypolipidemic therapy with rosuvastatin and ezetimibe is the key to success in the treatment and prevention of cardiovascular diseases;Meditsinskiy sovet = Medical Council;2024-05-09

2. Economic aspects of the fixed combinations of lipid lowering medicines in group risks patients;Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice;2023-07-31

3. Outpatient Practice of Lipid-Lowering Therapy Prescription (According to the ARGO-3 Study);Rational Pharmacotherapy in Cardiology;2023-05-17

4. Efficiency of high-intensity therapy with rosuvastatin for secondary prevention of cardiovascular complications in patients with a very high risk;Aterotromboz = Atherothrombosis;2022-01-21